Abstract
The native plasma of patients suffering from renal insufficiency inhibited the parathyroid hormone (PTH), the vasopressin (VP) and the NaF-activated adenylate cyclase (AC) in bovine renal plasma membranes. A crude immunoglobulin fraction, prepared by (NH4)2SO4precipitation, decreased only the hormone, but not the NaF activated AC. Chromatography of the native plasma on a AcA 34 column revealed two peaks inhibiting the PTH and to a lesser extent the VP dependent AC. Only the second peak reduced the NaF stimulated cAMP production. None of the column samples inhibited the isoproterenol stimulated adenylate cyclase in turkey red blood cells. Further purification of the first peak on a Sepharose 6B column confirmed previous results that immunoglobulins may block the PTH receptor in the kidney. Repurification of the second peak of inhibition on a Bio-Gel P10 column suggested that small peptides crossreacting in the radioimmunoassay for PTH may desensitize the hormonal receptor.
Similar content being viewed by others
References
Arieff A.I., Massry S.G. Calcium metabolism of brain in acute renal failure. J. Clin. Invest. 53: 387, 1974.
Avram M.M., Jancu M., Morrow P., Feinfeld D., Huatuco A. Uremic syndrome in man: new evidence for parathor mone as a multisystem neurotoxin. 11: 59, 1979.
Massry S.G., Popovtzer M.M., Coburn J.W., Maxwell M.H., Makoff D.L., Kleeman C.R. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. N. Engl.J. Med. 279: 697, 1968.
Massry S.G., Goldstein D.A. The search for uremic toxin(s) “X” “X” = PTH. Clin. Nephrol. 11: 181, 1979.
Avram M.M., Alexis H., Rahman N., Son B., Jancu M. Decreased transfusional requirement following parathy roidectomy in long term hemodialysis. Proc. Am. Soc. Nephrol. 5: 5, 1971.
Bailey G.L., Griffith H.J.L., Merrill J.P. A vascular necrosis of the femoral head in patients on chronic hemodialysis. 18: 401, 1972.
Cantin M. Kidney, parathyroid and lipemia. Lab. Invest. 14: 1691, 1965.
Bogin E., Massay S.G., Harary J. Effect of parathyroid hormone on rat heart cells. J. Clin. Invest. 67: 1215, 1981.
Remuzzi G., Benigin A., Dodesini P., Schieppati A., Livio M., Poletti E., Mecca G., De-Gaetano G. Parathyroid hormone inhibits human platelet function. Lancet 1: 1321, 1981.
Scribener B.H., Babb A.L. Evidence for toxins of “middle” molecular weight. Kidney Int. 7: 349, 1975.
Juppner H., Bialasiewcz A.A., Hesch R.D. Autoantibodies to parathyroid hormone receptor. Lancet 2: 1222, 1978.
Smith B.R., Hall R. Thyroid-stimulating immunoglobulins in Graves’ disease. Lancet 2: 427, 1974.
Kahn C.R., Flier J.S., Bar R.S., Archer J.A., Gordon P., Martin M.M., Roth J. The syndromes of insulin resistance and acanthosis nigricans. N. Engl.J. Med. 294: 739, 1976.
Patrick J., Lindström J.M. Autoimmune response to acetylcholine receptor. Science 180: 871, 1973.
Bronlik P.D., Ston J., Pacowsky V. Effect of chronical renal failure on inactivation of parathormone by rat kidney tissue slices. Physiol. Bohemoslov. 21: 239, 1972.
Fitzpatrick D.F., Davenport G.R., Forte L., Landon E.J. Characterization of plasma membrane proteins in mallian kidney.I. Preparation of a membrane fraction and separation of the protein, J. Biol. Chem. 244: 3561, 1969.
Jüppner H., Mohr H., Hesch R.D. Adsorption of parathyrin: Pitfall for solid phase assays using radiolabeled antibodies? J. Clin. Chem. Clin. Biochem. 18: 585, 1980.
Albano J.D.M., Maudsley D.V., Brown B.L., Barnes G.D. A simplified procedure for the determination of adenyl ate cyclase activity. Biochem. Soc. Trans. 1: 411, 1973.
Hunter W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194: 495, 1962.
Gardner J.D., Klaeveman H.L., Bilezikian J.P., Aurbach G.D. Effect of β-adrenergic catecholamines on sodium transport in turkey erythrocytes. J. Biol. Chem. 248: 5590, 1973.
Hehrmann R., Wilke R., Nordmeyer J.P., Hesch R.D. Hochsensitiver, C-terminal-spezifischer Radioimmuno assay für menschliches Parathormon als Routineme thode. Dtsch. Med. Wochenschr. 101: 1726, 1976.
Dom-Quint G., Montz R., Dietel M., Mohr H. PTH content and biological activity of P2-Hamburg. Acta Endocrinol. (Kbh.) (suppl.) 234: 120, 1980.
Hehrmann R., Normeyer J.P., Mohr H., Hesch R.D. Human parathyroid hormone: antibody characterization. J. Immunoassay 2: 151, 1980.
Nolte H., Mühlen A.V.Z., Hesch R.D. unter Mitarbeit von I. Pape, Warnecke U., Jüppner H. Auswertung radioimmunologischer Bestimmungsmethoden durch “Spline Approximation”. J. Clin. Chem. Clin. Biochem. 14: 253, 1976.
Yamada K., Saito Y., Tamura Y., Yamamoto M., Kumagai A. Effects of antibody to renal plasma membranes on urinary excretion of adenosin 3′, 5′-monophosphate and phosphate induced by parathyroid hormone infusion in rats. Endocrinology 106: 973, 1980.
Beck N., Singh H., Reed J.W., Davis B.H. Direct inhibitory effect of hypercalcemia on renal actions of parathyroid hormone. J. Clin. Invest. 53: 717, 1974.
Nielsen S.T., Neumann W.F. Effects of PTH and Ca2+ on renal adenyl cyclase. J. Supramol. Struct. 9: 391, 1978.
Rosenblatt M., Segre G.V., Potts J.T. Synthesis of a fragment of parathyroid hormone, bPTH-(28-48): An inhibitor of hormone cleavage in vivo. Biochemistry 16: 2811, 1977.
Waters M.J.W., Friesen H.G. Studies with anti-growth hormone receptor antibodies. J. Biol. Chem. 254, 6826, 1979.
Wasner H. Cyclo AMP Antagonist, ein neuer Hormonbote. In: Rensing L., Roth G. (Eds.), Zelluläre Kommunikationsund Kontrollmechanismen, ed. 2. Frühjahrskolloquium der Universität Bremen, 1978, P. 207.
Author information
Authors and Affiliations
Additional information
This work was presented in part at the VI International Congress of Endocrinology, Melbourne, Australia, 1980.
Supported by the Deutsche Forschungsgemeinschaft (DFG) HE 593/12.
Rights and permissions
About this article
Cite this article
Jüppner, H., Hesch, R.D. Inhibition of renal adenylate cyclase by plasma from uremic patients. J Endocrinol Invest 5, 303–309 (1982). https://doi.org/10.1007/BF03350518
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350518